Douglas Pharmaceuticals Limited

The US Food and Drug Administration is willing to loosen requirements for the Risk Evaluation and Mitigation Strategy (REMS) for the acne medication isotretinoin if manufacturers can come up with a so

Four years after Pfizer acquired Icagen for $56m, the big pharma sold the drug discovery firm to XRpro Sciences for up to $11m, which would seem to be a big discount if the deal gave the buyer access

The FDA on 1 April unveiled its final guidance advising makers of brand-name opioids about what they need to do to obtain abuse-deterrent language in the labeling of their products. The document, Gui

Actavis CEO Brent Saunders has been the head of three different companies in less than two years, but with the $66bn acquisition of Allergan about to close any day now, he told Scrip that he's found